Reauthorizes animal disease prevention and management programs under the Animal Health Protection Act and sets specific funding levels for those programs. It designates mandatory Commodity Credit Corporation (CCC) funding and requires minimum allocations to particular program areas across multiple upcoming fiscal years, and it increases/updates authorized funding for the National Animal Health Laboratory Network.
Amends 7 U.S.C. 8308a(d)(1) to require that, of CCC funds, the Secretary make available $30,000,000 for each of fiscal years 2023 through 2025; of that amount, not less than $18,000,000 must be made available each year to carry out subsection (b).
Amends 7 U.S.C. 8308a(d)(1) to require that, of CCC funds, the Secretary make available $233,000,000 for each of fiscal years 2026 through 2029; of that amount, not less than $10,000,000 must be made available each year to carry out subsection (a), not less than $70,000,000 each year to carry out subsection (b), and not less than $153,000,000 each year to carry out subsection (c).
Amends 7 U.S.C. 8308a(d)(1) to require that, of CCC funds, the Secretary make available $75,000,000 for fiscal year 2031 and each fiscal year thereafter; of that amount, not less than $45,000,000 must be made available each fiscal year to carry out subsection (b).
Amends 7 U.S.C. 8308a(d)(2)(A) to authorize appropriations, in addition to paragraph (1), for carrying out subsection (a): $30,000,000 for each of fiscal years 2019 through 2025, and $45,000,000 for each of fiscal years 2026 through 2030.
Amends 7 U.S.C. 8308a(d)(2)(B) (National animal disease preparedness and response program; national animal vaccine and veterinary countermeasures bank) by striking and inserting [text not provided in this section excerpt].
Directly affected parties include livestock and poultry producers, commercial farm owners/operators, and diagnostic laboratories. State animal health agencies and USDA program offices will implement and manage awarded funds. The legislation makes funding for surveillance, prevention, and response more predictable by using mandatory CCC funding and by specifying minimum allocations, which can improve laboratory capacity, speed of diagnostics, and readiness for outbreaks. Increased lab-network funding should strengthen disease detection and coordination across federal, state, and private labs. Fiscal impacts flow through the CCC funding mechanism rather than the annual discretionary appropriations process; that shifts program financing to mandatory spending authority. Trade and market access could benefit indirectly from improved disease control, while program recipients (labs, states, producers) will see more stable funding streams; administrative burdens may increase for grant management and compliance.
Referred to the House Committee on Agriculture.
Last progress June 11, 2025 (8 months ago)
Introduced on June 11, 2025 by Ronny Jackson